NutriProtect
Food supplement declared in France, declaration No 2023-4-314, decision dated 7 April 2023
NutriProtect is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- Metagenics France
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Powder
- Daily dose
- 1 mesurette (= ½ portion = 28 g) 1 ou 2 fois par j
- Directions for use
- 1 mesurette (= ½ portion = 28 g) 1-2 fois par jour. Mélanger à 125 ml d’eau fraîche, de jus d’ora
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Pregnant women, Taking anticoagulants, Taking medication
Declaration 242541, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Bambusa vulgaris Schrad. | Tige | Extrait sec hydroalcoolique | 316.7 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Protéines de riz | not declared |
| Inuline | not declared |
| L-Glutamine | not declared |
| Triglycérides à chaine moyenne | not declared |
| Bitartrate de choline | not declared |
| Chlorhydrate de lysine | not declared |
| Thréonine | not declared |
| Glutathion | not declared |
| Acétylcystéine | not declared |
| Chlorhydrate de L-cystéine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothénate de calcium | Acide pantothénique (vitamine B5) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| D-biotine | Biotine (vitamine B8) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Béta-carotène | Bêta-carotène | pas de limite (données insuffisantes) | no fixed dose |
| Picolinate de chrome | Chrome | pas de limite (données insuffisantes) | 25 µg |
| Gluconate de cuivre | Cuivre | 5,000 µg | 2,000 µg |
| Gluconate ferreux | Fer | 40 mg (safe level) | 14 mg |
| L-méthylfolate de calcium | Folates (vitamine B9) | 1,000 µg | 200 µg |
| Iodure de potassium | Iode | 600 µg | 150 µg |
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Citrate de potassium - magnésium | Magnésium | 250 mg | 300 mg |
| Molybdate de potassium | Molybdène | 600 µg | 150 µg |
| Nicotinamide | Nicotinamide (vitamine B3) | 900 mg | 54 mg |
| Citrate de potassium | Potassium | pas de limite (données insuffisantes) | 80 mg |
| L-sélénométhionine | Sélénium | 255 µg | 50 µg |
| Palmitate de rétinyle | Vitamine A | 3,000 µg d'équivalent rétinol | 800 µg |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Méthylcobalamine | Vitamine B12 | pas d'effet indésirable défini | dose annulled by the French Council of State in 2011 |
| Riboflavine | Vitamine B2 (riboflavine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Pyridoxal 5'-phosphate | Vitamine B6 | 12 mg | 2 mg |
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
| Acétate de D-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
| Phylloquinone | Vitamine K | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Citrate de zinc | Zinc | 25 mg | 15 mg |
Additives
Citrate de calcium, E341, E412, E340, E300
Other ingredients
sirop de riz déshydraté, farine de riz, huile d'olive
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux femmes enceintes ou désireuse de l'être, ansi qu'aux femmes ménopausées. Déconseillé aux fumeurs.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- L-Glutamine
Read the warning, when it applies and the studies cited
L-Glutamine
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Acétylcystéine
Read the warning, when it applies and the studies cited
N-ACETYL-L-CYSTEINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).
Sources cited by Health Canada (2)
- Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
- Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed
Contraindications
Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).
Sources cited by Health Canada (4)
- Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
- Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
- Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
- Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- NutriProtect Metagenics France, declared in 2024 : different composition: 11 ingredient(s) added, 8 missing
- Nutri Protect Vyséo, declared in 2021 : different composition: 11 ingredient(s) added, 42 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.